Syra Health Statistics
Total Valuation
Syra Health has a market cap or net worth of 6.72 million. The enterprise value is 3.87 million.
| Market Cap | 6.72M |
| Enterprise Value | 3.87M |
Important Dates
The last earnings date was Thursday, May 7, 2026.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Syra Health has 17.34 million shares outstanding. The number of shares has decreased by -31.14% in one year.
| Current Share Class | 11.34M |
| Shares Outstanding | 17.34M |
| Shares Change (YoY) | -31.14% |
| Shares Change (QoQ) | +7.05% |
| Owned by Insiders (%) | 38.71% |
| Owned by Institutions (%) | n/a |
| Float | 6.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.88 |
| PB Ratio | 2.84 |
| P/TBV Ratio | 2.84 |
| P/FCF Ratio | 8.89 |
| P/OCF Ratio | 8.89 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -21.14 |
| EV / Sales | 0.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 5.12 |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.48 |
| Quick Ratio | 2.40 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.10 |
| Interest Coverage | -19.20 |
Financial Efficiency
Return on equity (ROE) is -7.60% and return on invested capital (ROIC) is -5.97%.
| Return on Equity (ROE) | -7.60% |
| Return on Assets (ROA) | -3.91% |
| Return on Invested Capital (ROIC) | -5.97% |
| Return on Capital Employed (ROCE) | -10.16% |
| Weighted Average Cost of Capital (WACC) | 23.84% |
| Revenue Per Employee | 119,402 |
| Profits Per Employee | -2,861 |
| Employee Count | 89 |
| Asset Turnover | 1.99 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +222.92% in the last 52 weeks. The beta is 3.58, so Syra Health's price volatility has been higher than the market average.
| Beta (5Y) | 3.58 |
| 52-Week Price Change | +222.92% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 0.15 |
| Relative Strength Index (RSI) | 46.73 |
| Average Volume (20 Days) | 25,833 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Syra Health had revenue of 7.64 million and -183,089 in losses. Loss per share was -0.02.
| Revenue | 7.64M |
| Gross Profit | 2.87M |
| Operating Income | -240,007 |
| Pretax Income | -183,089 |
| Net Income | -183,089 |
| EBITDA | -221,522 |
| EBIT | -240,007 |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 2.92 million in cash and 73,086 in debt, with a net cash position of 2.85 million or 0.16 per share.
| Cash & Cash Equivalents | 2.92M |
| Total Debt | 73,086 |
| Net Cash | 2.85M |
| Net Cash Per Share | 0.16 |
| Equity (Book Value) | 2.36M |
| Book Value Per Share | 0.14 |
| Working Capital | 2.35M |
Cash Flow
In the last 12 months, operating cash flow was 755,968 and capital expenditures -107, giving a free cash flow of 755,861.
| Operating Cash Flow | 755,968 |
| Capital Expenditures | -107 |
| Depreciation & Amortization | 18,485 |
| Net Borrowing | -324,128 |
| Free Cash Flow | 755,861 |
| FCF Per Share | 0.04 |
Margins
Gross margin is 37.56%, with operating and profit margins of -3.14% and -2.40%.
| Gross Margin | 37.56% |
| Operating Margin | -3.14% |
| Pretax Margin | -2.40% |
| Profit Margin | -2.40% |
| EBITDA Margin | -2.90% |
| EBIT Margin | -3.14% |
| FCF Margin | 9.89% |
Dividends & Yields
Syra Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 31.14% |
| Shareholder Yield | 31.14% |
| Earnings Yield | -2.72% |
| FCF Yield | 11.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |